SUMMARY The hypothalamus receives a rich supply of adrenergic and noradrenergic nerve fibres from the brain stem, terminating in many hypothalamic regions, including the paraventricular nucleus, which is the site of the cell bodies of corticotrophin releasing factor (CRF) neurones in man. Experimental evidence has shown that an a, adrenoceptor mechanism stimulates adrenocorticotrophic hormone (ACTH) secretion in man. The site of action of this mechanism seems to be within the blood brain barrier, presumably modulating the secretion of the CRF complex. This mechanism is important in the control of ACTH secretion in some physiological conditions in healthy subjects.
The pioneering work of Harris' postulated the existence of a hypothalamic corticotrophin releasing factor (CRF) that is transported in the hypothalamohypophyseal portal system to the anterior pituitary gland, and which stimulates the secretion of adrenocorticotrophic hormone (ACTH). This work was crowned by Vale et al, who isolated and synthesised2 a 41 amino acid peptide from ovine hypothalami with specific CRF bioactivity. Equivalent peptides have been identified in other species, including man.
Immunohistochemical studies have shown this peptide to be widely distributed in the central nervous system, but within the hypothalamus it is localised mostly in the parvocellular neurones of the paraventricular nucleus. The axons extend to the zona externa of the median eminence, which is the site of the first capillary bed in the hypothalamohypophyseal portal system. [3] [4] [5] Further investigations have shown that other peptides may possess CRF activity. Prominent among these is vasopressin, which has a weak direct stimulant effect on ACTH secretion; but more importantly, it strongly enhances the activity of CRF-41 6 It therefore seems that the hypothalamus secretes a CRF "complex" the constituents of which may vary under different circumstances. The paraventricular nucleus contains high concentrations of catecholamines which may influence the activity of the hypothalamopituitary adrenal axis (HPAA). In theory peripheral circulating catecholamines may also influence ACTH secretion as activation of the sympathoadrenal system often accompanies that of the HPAA.
In this review, we summarise the relation of catecholamine systems to the hypothalamus and the pituitary gland and discuss the evidence from human experiments for a regulatory role of these amines in ACTH secretion.
Catecholamine systems, the hypothalamus, and the pituitary gland The hypothalamus contains the highest concentrations of noradrenaline in the brain.7-9 The origin of this noradrenaline is almost all extrinsic as surgical isolation of the hypothalamus results in a drastic reduction of its noradrenaline content.'0" The noradrenergic innervation of the hypothalamus is derived from parts of the reticular formation in the ventral and dorsal medulla oblongata and the locus ceruleus at the junction of the pons and the midbrain.
The axons ascend in the medial forebrain bundle, and some cross the midline.12 -16 Noradrenergic nerve terminals can be identified in every hypothalamic nucleus, but two of the most densely innervated are the paraventricular and supraoptic nuclei12 14 
Effects of catecholamines on A CTH secretion
The hypothalamus also contains high concentrations of adrenaline.7 The cell bodies of adrenergic neurones lie within the reticular formation in the upper medulla23 24 and project to various parts of the brain, including the diencephalon, in which the highest concentrations are found in the paraventricular and arcuate nuclei and the median eminence.23-27 Using combined immunocytochemistry Mezey et a!28 showed that adrenergic neurones lie in close proximity to CRF-41 cell bodies in the paraventricular nucleus of rats.
The dopaminergic innervation of the hypothalamus is almost all intrinsic; surgical isolation of the hypothalamus results in little reduction of dopamine content.'0 '" In the hypothalamus the tuberoinfundibular dopaminergic tract has its cell bodies in the arcuate nucleus, near the inferior end of the third ventricle. The axons project to the zona externa of the median eminence where they are in close proximity to the first capillary bed of the hypothalamo-hypophyseal portal system, into which dopamine is secreted. Dopaminergic neurones also supply the neural and the intermediate lobes of the rat pituitary.'2 18 The incerto-hypothalamic tract has its cell bodies mainly in the zona incerta and partly innervates the paraventricular nucleus. 29 The mammalian adenohypophysis does not receive a catecholaminergic innervation. 30 32 it is unlikely that the anterior pituitary is exposed to much higher concentrations of adrenaline than those found in peripheral plasma.
The distribution of adrenoceptors in the hypothalamus has been studied using autoradiography and radioligand binding studies on homogenised rat brain membranes. Within the hypothalamus, a, and a2 adrenoceptors are found in several nuclei, including the paraventricular nucleus.4" The median eminence has a high density of a2 adrenoceptors but no high al binding.4' The density of,-adrenoceptor binding sites is lower in the hypothalamus than in the cerebral cortex, and even lower densities are found in the adenohypophysis, about 10% of the density in the cortex.42 Roughly equal densities of the two P-adrenoceptor subtypes are found in the hypo- adrenaline may attenuate the cortisol response to hypoglycaemia induced by insulin, but this is probably attributable to the attenuation of the hypoglycaemic effect of insulin by adrenaline. Other evidence from man includes the observations that amphetamines stimulate the secretion of ACTH and cortisol and that the effect is blocked by thymoxamine but not propranolol, which suggests that it is mediated by a, adrenoceptors.55 56 Amphetamines have complex pharmacological actions and cause a generalised arousal effect that is correlated with the height of the cortisol peak,55 57 so the mechanism by which they stimulate ACTH secretion is uncertain.
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In our current investigations of a-adrenergic agonists we have chosen methoxamine, a highly selective agonist at post-synaptic a, adrenoceptors58 59 that is free of behavioural arousal effects when injected intracerebroventricularly in experimental animals.60
Like Nakai et al,6" we found that intravenous infusions of methoxamine stimulate the secretion of ACTH and cortisol in man (fig 1) . 62 The stimulant effects of methoxamine on ACTH and cortisol secretion were dose dependent and were accompanied by an increase in blood pressure, as may be expected from an oa, adrenoceptor agonist. 62 The effects of methoxamine were abolished by concomitant administration of the highly selective a, adrenoceptor antagonist thymoxamine,59 confirming that they were mediated by a, adrenoceptors (fig 1) . 62 When given in large doses in experimental animals, methoxamine may have P-adrenoceptor antagonist activity,63 but this is not the mechanism by which it stimulates the HPAA in man: the effect was abolished by concomitant administration of thymoxamine, which lacks activity at fl-adrenoceptors.64 Thymoxamine has weak H-l antihistaminic action on the guinea pig ileum in vitro,64 but we have found that thymoxamine does not attenuate the bronchoconstrictor action of intravenously injected histamine,65 suggesting that thymoxamine has no H-i antihistaminic activity in the doses used in man.
To examine whether methoxamine stimulates ACTH secretion by a central effect or by a peripheral action, such as vasoconstriction or an increase in blood pressure, we compared the effects of methoxamine to those of the more hydrophilic noradrenaline. 66 Noradrenaline is a potent a, adrenoceptor agonist58 that reaches the pituitary gland and the median eminence after a systemic injection but does not cross the blood brain barrier. [67] [68] [69] The noradrenaline infusions were designed to raise systolic blood pressure by amounts equivalent to those produced by methoxamine, so that equivalent peripheral a, adrenoceptor activation by the two drugs could be compared. 62 Fig 2 shows that the noradrenaline infusions were not followed by a rise in plasma cortisol above the mean control value, suggesting that the stimulation of the HPAA by methoxamine is exerted by a central rather than a peripheral mechanism. As the pituitary gland and the median eminence are outside the blood brain barrier and are accessible to circulating noradrenaline,6769 our inability to stimulate the HPAA with noradrenaline suggests that the site of the stimulant a1 adrenoceptors is within the blood brain barrier, presumably modulating the secretion of the CRF complex.
In addition to its hydrophilic properties, noradrenaline differs from methoxamine in its ,B and a2 adrenoceptor agonist actions. These receptor Al-Damluji, Rees activities of noradrenaline, however, do not account for the differences from methoxamine, as we found that fJ and f2 adrenoceptor agonists (prenalterol and salbutamol, respectively), do not have a direct action on ACTH secretion in man; and an U2 antagonist (yohimbine) does not modify cortisol secretion during noradrenaline infusions. 62 The noradrenaline infusions caused a slight inhibition of cortisol secretion compared with saline septicaemia with shock,82 and after the pharmacological stimulus of hypoglycaemia induced by insulin. It was therefore concluded that circulating adrenaline has no physiological role in stimulating ACTH secretion either basally or in the presence of CRF-41. This conclusion is compatible with the previous findings that peripheral adrenergic stimulation with noradrenaline, prenalterol, and salbutamol was not associated with activation of the pituitary adrenal axis. The possibility that hypophyseal portal plasma may contain somewhat higher concentrations of adrenaline derived from a central source is controversial and has been discussed here. Milsom et a183 studied the effects of adrenaline, noradrenaline, and clonidine and found no enhancement of the action of synthetic ovine CRF-41 by any of these substances.
In our investigation of the interaction of adrenaline and CRF-41 the adrenaline infusions were associated with a transient inhibition of ACTH secretion basally and a slowing of the rate of rise of ACTH secretion after the injection of CRF-41. This is compatible with the previously described inhibition of cortisol Al-Damluji, Rees secretion by noradrenaline described above, and localises the site of action of this effect to the pituitary gland.
The effects of clonidine on the activity of the HPAA have also been examined, with conflicting results: the drug has been reported both to inhibit84 85 and to have no effect86 87 on corticotroph activity. This may perhaps be due to the drug's complex pharmacology, as it stimulates both tx, and a2 adrenoceptors, the latter having the effect of inhibition of noradrenaline release from nerve endings. Clonidine also causes hypotension, which is a potent stimulus to ACTH secretion,8889 and sedation,60 which would be expected to depress the HPAA.
The physiological importance of the stimulant a; adrenoceptors I THE ROLE OF a, ADRENOCEPTORS IN DETERMINING THE 24 HOUR CORTISOL SECRETORY PATTERN 90 A group of normal subjects were given 24 hour intravenous infusions of the a, adrenoceptor agonist methoxamine, the a, antagonist thymoxamine, and saline under double blind conditions. During waking hours, the methoxamine infusion was accompanied by higher concentrations of plasma cortisol than saline, while the converse held with thymoxamine ( fig 5) . In contrast, the nocturnal surge in cortisol secretion was unaffected by these adrenergic manipulations. The results suggest than an cxl adrenoceptor mechanism maintains cortisol secretion during waking hours but not at night. There is evidence from experimental animals that the nocturnal activity of the HPAA may be mediated by serotonergic and cholinergic mechanisms.
THE ROLE OF (XI ADRENOCEPTORS IN CORTISOL SECRETION AFTER FOOD
Food ingestion stimulates cortisol secretion in man by an unknown mechanism.9' In rats feeding increases the turnover of noradrenaline in the hypothalamus,92 so we investigated the role of a, adrenoceptors in the mediation ofcortisol secretion after eating.93 A group of normal subjects was given three hour intravenous infusions of saline, methoxamine, and thymoxamine, and a standard meal was eaten 60 
